Jan 31, 2023
On this episode we discuss the new drugs that have been approved in 2023 so far. We review Leqembi (lecanemab-irmb) injection for Alzheimer's disease, Airsupra (albuterol and budesonide) inhalation for as-needed use in asthma, and Brenzavvy (bexagliflozin) for type 2 diabetes. We also mention Rykindo (risperidone) ER...
Jan 23, 2023
On this episode, we discuss the pharmacotherapy options for
managing obsessive compulsive disorder (OCD). We based our
discussion on the treatment algorithm created by Dr David Osser.
All of Dr. Osser's work with the Psychopharmacology Algorithms
at the Harvard South Shore Psychiatry Residency Training...
Jan 9, 2023
On this episode, Cole and I review some of the updates that were published in the 2023 American Diabetes Association guidelines.
Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to...
Jan 6, 2023
Below is the patient case information:
63-year-old white male.
Bipolar II disorder
Epilepsy (tonic-clonic seizures)
Recent weight gain
History of hyponatremia
Diabetes type 2(controlled)
Clonazepam 2 mg QHS
Risperdal 2 mg twice daily
Dec 27, 2022
On this episode, we discuss the management of insomnia disorder. We review the criteria necessary for an insomnia disorder diagnosis. We then compare and contrast the pharmacotherapy options such as non-benzodiazepine hypnotics, benzodiazepines, anti-depressants, orexin receptor antagonists, and more.
Cole and I are...